Pathophysiology of obstructive sleep apnea-associated hypertension;Fisiopatología de la hipertensión asociada al síndrome de apnea obstructiva del sueño: Evidencia de estudios clínicos y modelos animales de hipoxia crónica intermitente

Revista Medica de Chile

Volumn 135, Issue 10, 2007, Pages 1333-1342

  Rey, Sergio ^a,b   Valdés, Gloria ^a   Iturriaga, Rodrigo ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Anoxemia; Hypertension; Obstructive; Sleep apnea

Indexed keywords

ANIMAL; ANOXIA; CHRONIC DISEASE; DISEASE MODEL; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; REVIEW; SLEEP APNEA SYNDROME;

ANIMALS; ANOXIA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; SLEEP APNEA, OBSTRUCTIVE;

EID: 37049000394     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. PARTINEM M. Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med 1995; 1: 482-7.
2. YOUNG T, PALTA M, DEMPSEY J, SKATRUD J, WEBER S, BADR S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
3. STROLLO PJ, JR, ROGERS RM. Obstructive sleep apnea. N Engl J Med 1996; 334: 99-104.
4. AMERICAN ACADEMY OF SLEEP MEDICINE. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-89.
5. HLA KM, YOUNG TB, BIDWELL T, PALTA M, SKATRUD JB, DEMPSEY J. Sleep apnea and hypertension. A population-based study. Ann Intern Med 1994; 120: 382-8.
6. ITURRIAGA R, REY S, DEL RÍO R. Cardiovascular and ventilatory acclimatization induced by chronic intermittent hypoxia: a role for the carotid body in the pathophysiology of sleep apnea. Biol Res 2005; 38: 335-40.
7. KELMAN GR. Digital computer subroutine for the conversion of oxygen tension into saturation. J Appl Physiol 1966; 21: 1375-6.
8. BROOKS D, HORNER RL, KIMOFF RJ, KOZAR LF, RENDER-TEIXEIRA CL, PHILLIPSON EA. Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med 1997; 155: 1609-17.
9. QUAN SF, GERSH BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation 2004; 109: 951-7.
10. MILLMAN RP, REDLINE S, CARLISLE CC, ASSAF AR, LEVINSON PD. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 1991; 99: 861-6.
11. ROUX F, D'AMBROSIO C, MOHSENIN V. Sleep-related breathing disorders and cardiovascular disease. Am J Med 2000; 108: 396-402.
12. LOGAN AG, TKACOVA R, PERLIKOWSKI SM, LEUNG RS, TISLER A, FLORAS JS, BRADLEY TD. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241-7.
13. SMITH ML, MUENTER NK. Effects of hypoxia on sympathetic neural control in humans. Respir Physiol 2000; 121: 163-71.
14. NARKIEWICZ K, VAN DE BORNE PJ, COOLEY RL, DYKEN ME, SOMERS VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98: 772-6.
15. NARKIEWICZ K, VAN DE BORNE PJ, MONTANO N, DYKEN ME, PHILLIPS BG, SOMERS VK. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998; 97: 943-5.
16. NARKIEWICZ K, VAN DE BORNE PJ, PESEK CA, DYKEN ME, MONTANO N, SOMERS VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999; 99: 1183-9.
17. ROBINSON GV, STRADLING JR, DAVIES RJ. Obstructive sleep apnoea/hypopnoea syndrome and hypertension. Thorax 2004; 59: 1089-94.
18. WOLK R, SHAMSUZZAMAN AS, SOMERS VK. Obesity, sleep apnea, and hypertension. Hypertension 2003; 42: 1067-4.
19. PEPPARD PE, YOUNG T, PALTA M, SKATRUD J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
20. SOMERS VK, DYKEN ME, CLARY MP, ABBOUD FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-904.
21. PEPPERELL JC, RAMDASSINGH-DOW S, CROSTHWAITE N, MULLINS R, JENKINSON C, STRADLING JR, DAVIES RJ. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel trial. Lancet 2002; 359: 204-10.
22. NORMAN D, LOREDO JS, NELESEN RA, ANCOLI-ISRAEL S, MILLS PJ, ZIEGLER MG, DIMSDALE JE. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006; 47: 840-5.
23. CHOBANIAN AV, BAKRIS GL, BLACK HR, CUSHMAN WC, GREEN LA, IZZO JL JR ET AL. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
24. NARKIEWICZ K, MONTANO N, COGLIATI C, VAN DE BORNE PJ, DYKEN ME, SOMERS VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98: 1071-7.
25. PENG YJ, PRABHAKAR NR. Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. J Appl Physiol 2003; 94: 2342-9.
26. PENG YJ, PRABHAKAR NR. Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity. J Appl Physiol 2004; 96: 1236-42.
27. REY S, DEL RÍO R, ALCAYAGA J, ITURRIAGA R. Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia. J Physiol 2004; 560: 577-86.
28. REY S, DEL RÍO R, ITURRIAGA R. Contribution of endothelin-1 to the enhanced carotid body chemosensory responses induced by chronic intermittent hypoxia. Brain Res 2006; 1086: 152-9.
29. FLETCHER EC, LESSKE J, BEHM R, MILLER CC, 3RD, STAUSS H, UNGER T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 1992; 72: 1978-84.
30. FLETCHER EC BAO G, LI R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999; 34: 309-14.
31. KANAGY NL, WALKER BR, NELIN LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001; 37: 511-5.
32. LAI CJ, YANG CC, HSU YY, LIN YN, KUO TB. Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats. J Appl Physiol 2006; 100: 1974-82.
33. FLETCHER EC. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol 2000; 119: 189-197.
34. GREENBERG HE, SICA A, BATSON D, SCHARF SM. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 1999; 86: 298-305.
35. LEUENBERGER UA, BRUBAKER D, QURAICHI S, HOGEMAN CS, IMADOJEMU VA, GRAY KS. Effects of intermittent hypoxia on sympathetic activity and blood pressure in humans. Auton Neurosci 2005; 121: 87-93.
36. HOY LJ, EMERY M, WEDZOCHA JA, DAVISON AG, CHEW SL, MONSON JP, METCALFE KA. Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report. J Clin Endocrinol Metab 2004; 89: 2033-8.
37. MAKINO S, IWATA M, FUJIWARA M, IKE S, TATEYAMA H. A case of sleep apnea syndrome manifesting severe hypertension with high plasma norepinephrine levels. Endocr J 2006; 53: 363-9.
38. LEVY MN, MARTIN PJ, STUESSE SL. Neural regulation of the heart beat. Annu Rev Physiol 1981; 43: 443-53.
39. KAMATH MV, FALLEN EL. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng 1993; 21: 245-311.
40. LEE ST, HON EH. Electronic evaluations of the fetal heart rate preceeding fetal death, further observations. Am J Obstet Gynecol 1965; 87: 814-26.
41. HIRSCH JA, BISHOP B. Respiratory sinus arrhythmia in humans: how breathing pattern modulates heart rate. Am J Physiol 1981; 241: H620-9.
42. LUCZAK H, LAURIG W. An analysis of heart rate variability. Ergonomics 1973; 16: 85-97.
43. SAYERS BM. Analysis of heart rate variability. Ergonomics 1973; 16: 17-32.
44. AKSELROD S, GORDON D, UBEL FA, SHANNON DC, BERGER AC, COHEN RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220-2.
45. TASK FOORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND THE NORTH AMERICAN SOCIETY OF PACING AND ELECTROPHYSIOLOGY. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-81.
46. POMERANZ B, MACAULAY RJ, CAUDILL MA, KUTZ I, ADAM D, GORDON D ET AL. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985; 248: H151-3.
47. PAGANI M, MONTANO N, PORTA A, MALLIANI A, ABBOUD FM, BIRKETT C, SOMERS VK. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997; 95: 1441-8.
48. THRASHER TN. Baroreceptors and the long-term control of blood pressure. Exp Physiol 2004; 89: 331-5.
49. BONSIGNORE MR, PARATI G, INSALACO G, MARRONE O, CASTIGLIONI P, ROMANO S ET AL. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002; 166: 279-286.
50. JO JA, BLASI A, VALLADARES E, JUÁREZ R, BAYDUR A, KHOO MC. Determinants of heart rate variability in obstructive sleep apnea syndrome during wakefulness and sleep. Am J Physiol Heart Circ Physiol 2005; 288: H1103-12.
51. PARATO G, DI RIENZO M, BONSIGNORE MR, INSALACO G, MARRONE O, CASTIGLIONI P ET AL. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 1997; 15: 1621-6.
52. DAVENPORT AP. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 2002; 54: 219-26.
53. ELTON TS, OPARIL S, TAYLOR GR, HICKS PH, YANG RH, JIN H, CHEN YF. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am J Physiol 1992; 263: R1260-4.
54. PHILLIPS BG, NARKIEWICZ K, PESEK CA, HAYNES WG, DYKEN ME, SOMERS VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17: 61-6.
55. SAARELAINEN S, SEPPALA E, LAASONEN K, HASAN J. Circulating endothelin-1 in obstructive sleep apnea. Endothelium 1997; 5: 115-8.
56. GRIMPEN F, KANNE P, SCHULZ E, HAGENAH G, HASENFUSS G, ANDREAS S. Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 2000; 15: 320-5.
57. NI Z, BEMANIAN S, KIVLIGHN SD, VAZIRI ND. Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension. Kidney Int 1998; 54: 188-92.
58. WONG-DUSTING HK, LA M, RAND MJ. Endothelin-1 enhances vasoconstrictor responses to sympathetic nerve stimulation and noradrenaline in the rabbit ear artery. Clin Exp Pharmacol Physiol 1991; 18: 131-6.
59. FERNÁNDEZ N, SÁNZ E, MONGE L, MARTÍNEZ MA, DIEGUEZ G, GARCÍA- VILLALÓN AL. Potentiation by endothelin-1 and vasopressin of sympathetic vasoconstriction in male and female rats. Clin Sci (Lond) 2002; 103: 158S-161S.
60. KUWAKI T, KURIHARA H, CAO WH, UNEKAWA M, YAZAKI Y, KUMADA M. Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse. Prog Neurobiol 1997; 51: 545-79.
61. MOLLER DS, LIND P, STRUNGE B, PEDERSEN EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16: 274-80.
62. YUAN ZM, CHEN BY, WANG PX, LI SY, CHEN YL, DONG LX. Changes of angiotensin II and its receptor during the development of chronic intermittent hypoxia-induced hypertension in rats. Zhonghua Jie He He Hu Xi Za Zhi 2004; 27: 577-80.
63. THONGBOONKERD V, GOZAL E, SACHLEBEN LR, JR., ARTHUR JM, PIERCE WM, CAI J ET AL. Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. J Biol Chem 2002; 277: 34708-16.
64. DUCHNA HW, ORTH M, SCHULTZE-W ERNINGHAUS G, GUILLE C, STOOHS RA. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath 2005; 9: 97-103.
65. DUCHNA HW, ORTH M, SCHULTZE-W ERNINGHAUS G, GUILLEMINAULT C, STOOHS RA. Antihypertensive treatment and endothelium-dependent venodilation in sleep-disordered breathing. Sleep Breath 2006; 10:115-22.
66. IP MS, LAM B, CHAN LY, ZHENG L, TSANG KW, FUNG PC, LAM WK. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162: 2166-71.
67. OHIKE Y, KOZAKI K, IIJIMA K, ETO M, KOJIMA T, OHGA E ET AL. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure - possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005; 69: 221-6.
68. TERAMOTO S, KUME H, MATSUSE T, ISHII T, MIYASHITA A, AKISHITA M ET AL. Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome. Sleep Med 2003; 4: 403-7.
69. LAVIE L, VISHNEVSKY A, LAVIE P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004; 27: 123-8.
70. YAUMAUCHI M, NAKANO H, MAEKAWA J, OKAMOTO Y, OHNISHI Y, SUZUKI T, KIMURA H. Oxidative stress in obstructive sleep apnea. Chest 2005; 127: 1674-9.
71. IP MS, LAM B, NG MM, LAM WK, TSANG KW, LAM KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-6.
72. PUNJABI NM, SORKIN JD, KATZEL LI, GOLDBERG AP, SCHWARTZ AR, SMITH PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-82.
73. SHEK EW, BRANDS MW, HALL JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409-14.